cBHT Prescriber Survey
PLEASE SHARE: From APC
IMPORTANT!!!
cBHT Prescriber Survey
|
In light of NASEM's FDA-funded cBHT study, which discourages the use of cBHT preparations, APC is helping to gather evidence from physicians that support the safety and efficacy of cBHT.
APC has developed a brief survey on Google Forms, which will take no more than 5 minutes for your physicians to fill out.
Compounded Hormones for Female Patients is a survey assessment of prescribing habits and methods used to evaluate the safety and efficacy of female compounded hormones. This survey includes an invitation to contribute with potential case studies for scientific publication.
If your physicians choose to participate, it will facilitate the gathering of large amounts of real data that will be vital in establishing the safety and efficacy of cBHT.
Responses are required by February 15, 2021.
Your contribution is very important to protect millions of Americans who use cBHT every day. Please share this survey with your prescribers of cBHT:
Compounded Hormones for Female Patients
Together we can save cBHT.
Scott Brunner, CAE
Chief Executive Officer
|